BIVDA Press Releases

02Dec

Press Release - BIVDA welcomes approval of new COVID-19 vaccine

 

BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators.

 

Doris-Ann said;

 

“We are delighted that the MHRA have approved the Pfizer/BioNTech coronavirus vaccine for widespread use, meaning it can start its roll out from next week. On behalf of BIVDA and the in vitro diagnostics sector, I would like to congratulate all those involved in this incredible scientific achievement.

 

An effective vaccine, combined with an effective test and trace system, is our best route back to normality, and indeed both prongs of this approach are interdependent. We will continue to work closely with the MHRA, NHS and Ministers to play our role in supporting the continued implementation of effective and rapid COVID-19 testing, so cases can be detected and controlled while the vaccine is being distributed.

 

Once the virus is on the retreat, the Government must continue to support the NHS to restart and scale up routine testing to avoid a tsunami of undiagnosed illnesses presenting themselves next year, just when pressure on the NHS from COVID-19 may begin to ease. Our members stand ready to play their part in the next stage of this important endeavour.”

 

ENDS

 

 

For more information please contact BIVDA External Affairs Manager Jon Harrison jonh@bivda.org.uk

Related

BIVDA response to the Secretary of State for Health and Social Care's vision for prevention

Today the Secretary of State for Health and Social Care, Matt Hancock MP, has announced his vision f...

Read More >

UK continues to lag behind the European market for in-vitro diagnostic expenditure

IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...

Read More >

BIVDA responds to the final report of the Accelerated Access Review

Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final repo...

Read More >

BIVDA response to Parliament’s vote on the Brexit deal

Doris-Ann Williams, Chief Executive of BIVDA, comments on tonight's vote

Read More >

Statement from BIVDA Chief Executive on COVID-19 Testing Capacity

Please find below a statement from BIVDA Chief Executive Doris-Ann Williams regarding the new plans ...

Read More >

BIVDA and Diabetes UK call for urgent action on blood glucose monitoring

BIVDA and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and chec...

Read More >